Search Result

Results for "

B7-H3

" in MedChemExpress (MCE) Product Catalog:

By Targets:	ADC Antibody (2) Akt (1) Antibody-Drug Conjugates (ADCs) (2) Apoptosis (1) Autophagy (1) CD276/B7-H3 (7) CD3 (2) Drug-Linker Conjugates for ADC (1) EGFR (1) mTOR (1) Small Interfering RNA (siRNA) (3) STAT (1) Topoisomerase (1)
By Research Areas:	Cancer (12) Inflammation/Immunology (3)
Oligonucleotides:	Rat Pre-designed siRNA Sets (1) Mouse Pre-designed siRNA Sets (1) Human Pre-designed siRNA Sets (1) siRNAs (3)

Inhibitors & Agonists

Inhibitory Antibodies

Recombinant Proteins

Antibodies

Oligonucleotides

Cat. No.	Product Name	Target	Research Areas	Chemical Structure

HY-P990279

*Anti-Mouse CD276/B7-H3* Antibody (MJ18)**	CD276/B7-H3 Apoptosis STAT	Inflammation/Immunology Cancer
Anti-Mouse CD276/B7-H3 Antibody (MJ18) is a rat-derived anti-mouse *CD276/B7-H3* IgG1 monoclonal antibody. Anti-Mouse CD276/B7-H3 Antibody (MJ18) can inhibit CD276/B7-H3 and induce tumor cell apoptosis. Anti-Mouse CD276/B7-H3 Antibody (MJ18) enhances anti-tumor immune response by reducing immunosuppressive cells and promoting T cell activation. Anti-Mouse CD276/B7-H3 Antibody (MJ18) can be used for research on cancer such as breast cancer and prostate cancer .

HY-P9966

Enoblituzumab MGA271	CD276/B7-H3	Cancer
Enoblituzumab (MGA271) is a humanized IgG1κ monoclonal antibody recognizing human *B7-H3* protein, a member of the B7 family of immune regulators .

HY-P99367

Ifinatamab	CD3	Inflammation/Immunology Cancer
Ifinatamab is monoclonal immunoglobulin G1-kappa with anti-human B7 homolog 3 protein (Human B7-H3). Ifinatamab is a glycoforme α immunomodulateur .

HY-P99762

Obrindatamab 1 Publications Verification MGD009	CD3	Cancer
Obrindatamab is a humanized anti-B7-H3/CD3 bispecific antibody. Obrindatamab binds to B7-H3 and CD3, thereby mediating redirected cytotoxic T-lymphocyte (CTL) activity against B7-H3-expressing cancer cells. Obrindatamab can be used in research of cancer .

HY-P99157

Omburtamab	CD276/B7-H3	Cancer
Omburtamab is a humanized monoclonal antibody targeting B7-H3 (CD276). Omburtamab selectively binds to *B7-H3* highly expressed on the surface of tumor cells and activates anti-tumor immune responses mediated by T cells and natural killer (NK) cells. Omburtamab can promote the specific infiltration of CAR-T cells into tumors, enhance the killing function of NK cells through the CD16 signaling pathway, and regulate tumor cell glucose metabolism (such as inhibiting the Warburg effect). Omburtamab has the potential to inhibit solid tumors such as non-small cell lung cancer (NSCLC) .

HY-155747

FDW028	Autophagy Akt mTOR	Cancer
FDW028 a potent and highly selective FUT8 inhibitor. FUT8 exhibits potent anti-tumor activity by defucosylation and impelling lysosomal degradation of B7-H3 through the chaperone-mediated autophagy (CMA) pathway. FDW028 can be used for metastatic colorectal cancer (mCRC) research .

HY-P99101

Vobramitamab AEX-4089	ADC Antibody	Cancer
Vobramitamab is a humanized *B7-H3* monoclonal antibody (mAb). Vobramitamab conjugated with prodrug seco-DUBA (HY-132180A) via a cleavable linker, to form antibody-drug conjugate (ADC), the MGC018. MGC018 displays potent antitumor activity in preclinical tumor models of breast, ovarian, and lung cancer, as well as melanoma .

HY-P991092

IBI-334	EGFR CD276/B7-H3	Cancer
IBI-334 is a bispecific *B7-H3* and EGFR antibody. IBI-334 has an EGFR arm for signal blockage and is coupled with a fine-tuned B7-H3 arm with optimal affinity and binding domain. IBI-334 is afucosylated to enhance its antibody-mediated cell cytotoxicity (ADCC) effects. IBI-334 has a wide range of applications in many EGFR-driven solid tumors .

HY-P990340

*Anti-B7-H3/CD276 Antibody*	CD276/B7-H3	Inflammation/Immunology
Anti-B7-H3/CD276 Antibody is a CHO-expressed human antibody targeting *B7-H3/CD276. Anti-B7-H3/CD276 Antibody has a huIgG1 heavy chain and a huκ light chain, with a predicted molecular weight (MW) of 145 kDa. The isotype control for Anti-B7-H3*/CD276 Antibody can be referenced as Human IgG1 kappa, Isotype Control (HY-P99001).

HY-P991537

HS-20093 Antibody GSK5764227	Antibody-Drug Conjugates (ADCs) CD276/B7-H3	Cancer
HS-20093 Antibody is an antibody-drug conjugate (ADC) targeting *B7-H3*. HS-20093 Antibody exhibits anti-tumor activity. HS-20093 Antibody can be studied in research for small cell lung cancer, relapsed or refractory osteosarcoma, and advanced solid tumors .

HY-P99740

Mirzotamab	CD276/B7-H3 ADC Antibody	Cancer
Mirzotamab is an IgG1κ monoclonal antibody targeting to *CD276/B7-H3* with anti-tumor activity. Mirzotamab conjugates with Clezutoclax (HY-137774), a BCL inhibitor to form Mirzotamab clezutoclax (HY-P99741), involving in research with taxane research in relapsed/refractory solid tumors. Mirzotamab clezutoclax (ABBV-155) is a targeted antibody drug conjugate (ADC) .

HY-P3371

Ifinatamab deruxtecan DS-7300a; MABX-9001a	Antibody-Drug Conjugates (ADCs)	Cancer
Ifinatamab deruxtecan (DS-7300a) is an ADC that binds an anti-B7-H3 antibody to the DNA topoisomerase I inhibitory anti-tumor drug DXd. Ifinatamab deruxtecan has antitumor activity .

HY-RS17006

Cd276 Mouse Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
Cd276 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Cd276 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Cd276 Mouse Pre-designed siRNA Set A Cd276 Mouse Pre-designed siRNA Set A

HY-RS02220

CD276 Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
CD276 Human Pre-designed siRNA Set A contains three designed siRNAs for CD276 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CD276 Human Pre-designed siRNA Set A CD276 Human Pre-designed siRNA Set A

HY-RS23449

Cd276 Rat Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
Cd276 Rat Pre-designed siRNA Set A contains three designed siRNAs for Cd276 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

Cd276 Rat Pre-designed siRNA Set A Cd276 Rat Pre-designed siRNA Set A

HY-160649

MC-Gly-Gly-Phe-Gly-GABA-Exatecan	Drug-Linker Conjugates for ADC Topoisomerase	Cancer
MC-Gly-Gly-Phe-Gly-GABA-Exatecan is an agent linker conjugate for ADC, with an inhibitor for Topoisomerase Exatecan (HY-13631) with IC₅₀ of 22 μM. MC-Gly-Gly-Phe-Gly-GABA-Exatecan targets various antibodies, exhibits cytotoxic and antitumor efficacy in vitro and in vivo .

Cat. No.	Product Name	Target	Research Area

HY-P990279

*Anti-Mouse CD276/B7-H3* Antibody (MJ18)**	CD276/B7-H3 Apoptosis STAT	Inflammation/Immunology Cancer
Anti-Mouse CD276/B7-H3 Antibody (MJ18) is a rat-derived anti-mouse *CD276/B7-H3* IgG1 monoclonal antibody. Anti-Mouse CD276/B7-H3 Antibody (MJ18) can inhibit CD276/B7-H3 and induce tumor cell apoptosis. Anti-Mouse CD276/B7-H3 Antibody (MJ18) enhances anti-tumor immune response by reducing immunosuppressive cells and promoting T cell activation. Anti-Mouse CD276/B7-H3 Antibody (MJ18) can be used for research on cancer such as breast cancer and prostate cancer .

HY-P9966

Enoblituzumab MGA271	CD276/B7-H3	Cancer
Enoblituzumab (MGA271) is a humanized IgG1κ monoclonal antibody recognizing human *B7-H3* protein, a member of the B7 family of immune regulators .

HY-P99367

Ifinatamab	CD3	Inflammation/Immunology Cancer
Ifinatamab is monoclonal immunoglobulin G1-kappa with anti-human B7 homolog 3 protein (Human B7-H3). Ifinatamab is a glycoforme α immunomodulateur .

HY-P99762

Obrindatamab 1 Publications Verification MGD009	CD3	Cancer
Obrindatamab is a humanized anti-B7-H3/CD3 bispecific antibody. Obrindatamab binds to B7-H3 and CD3, thereby mediating redirected cytotoxic T-lymphocyte (CTL) activity against B7-H3-expressing cancer cells. Obrindatamab can be used in research of cancer .

HY-P99157

Omburtamab	CD276/B7-H3	Cancer
Omburtamab is a humanized monoclonal antibody targeting B7-H3 (CD276). Omburtamab selectively binds to *B7-H3* highly expressed on the surface of tumor cells and activates anti-tumor immune responses mediated by T cells and natural killer (NK) cells. Omburtamab can promote the specific infiltration of CAR-T cells into tumors, enhance the killing function of NK cells through the CD16 signaling pathway, and regulate tumor cell glucose metabolism (such as inhibiting the Warburg effect). Omburtamab has the potential to inhibit solid tumors such as non-small cell lung cancer (NSCLC) .

HY-P99101

Vobramitamab AEX-4089	ADC Antibody	Cancer
Vobramitamab is a humanized *B7-H3* monoclonal antibody (mAb). Vobramitamab conjugated with prodrug seco-DUBA (HY-132180A) via a cleavable linker, to form antibody-drug conjugate (ADC), the MGC018. MGC018 displays potent antitumor activity in preclinical tumor models of breast, ovarian, and lung cancer, as well as melanoma .

HY-P99740

Mirzotamab	CD276/B7-H3 ADC Antibody	Cancer
Mirzotamab is an IgG1κ monoclonal antibody targeting to *CD276/B7-H3* with anti-tumor activity. Mirzotamab conjugates with Clezutoclax (HY-137774), a BCL inhibitor to form Mirzotamab clezutoclax (HY-P99741), involving in research with taxane research in relapsed/refractory solid tumors. Mirzotamab clezutoclax (ABBV-155) is a targeted antibody drug conjugate (ADC) .

HY-P991092

IBI-334	EGFR CD276/B7-H3	Cancer
IBI-334 is a bispecific *B7-H3* and EGFR antibody. IBI-334 has an EGFR arm for signal blockage and is coupled with a fine-tuned B7-H3 arm with optimal affinity and binding domain. IBI-334 is afucosylated to enhance its antibody-mediated cell cytotoxicity (ADCC) effects. IBI-334 has a wide range of applications in many EGFR-driven solid tumors .

HY-P990340

*Anti-B7-H3/CD276 Antibody*	CD276/B7-H3	Inflammation/Immunology
Anti-B7-H3/CD276 Antibody is a CHO-expressed human antibody targeting *B7-H3/CD276. Anti-B7-H3/CD276 Antibody has a huIgG1 heavy chain and a huκ light chain, with a predicted molecular weight (MW) of 145 kDa. The isotype control for Anti-B7-H3*/CD276 Antibody can be referenced as Human IgG1 kappa, Isotype Control (HY-P99001).

HY-P991537

HS-20093 Antibody GSK5764227	Antibody-Drug Conjugates (ADCs) CD276/B7-H3	Cancer
HS-20093 Antibody is an antibody-drug conjugate (ADC) targeting *B7-H3*. HS-20093 Antibody exhibits anti-tumor activity. HS-20093 Antibody can be studied in research for small cell lung cancer, relapsed or refractory osteosarcoma, and advanced solid tumors .

HY-P3371

Ifinatamab deruxtecan DS-7300a; MABX-9001a	Antibody-Drug Conjugates (ADCs)	Cancer
Ifinatamab deruxtecan (DS-7300a) is an ADC that binds an anti-B7-H3 antibody to the DNA topoisomerase I inhibitory anti-tumor drug DXd. Ifinatamab deruxtecan has antitumor activity .

Recombinant Proteins Recommended:

B7-H3

Species:	Human (12) Rat (2) Mouse (2) Cynomolgus (2)
Tag:	His (11) Avi (5) Myc (1) Fc (7)
Source:	HEK293 (18)

Cat. No.	Compare	Product Name	Species	Source

HY-P74314

	*CD276/B7-H3* Protein, Rat (HEK293, His)** B7H3; B7-H3B7 homolog 3; CD276; Costimulatory molecule	Rat	HEK293
	CD276/B7-H3 Protein regulates T-cell-mediated immune responses and transplant rejection. It also promotes bone formation, functioning at the bone-immune interface. Additionally, it activates immune responses against tumors, eliminating them through natural killer cells and CD8 T-cells. Its interaction with TREML2 enhances T-cell activation, highlighting its role in immune regulation. CD276/B7-H3 Protein, Rat (HEK293, His) is the recombinant rat-derived CD276/B7-H3 protein, expressed by HEK293 , with C-His labeled tag.

HY-P70125

	*CD276/B7-H3* Protein, Cynomolgus (HEK293, His)** rCynCD276/B7-H3, His; CD276 antigen; CD276; B7 homolog 3; B7-H3; CD276; Cynomolgus CD276	Cynomolgus	HEK293
	CD276/B7-H3 protein can regulate T cell-mediated immune responses and act as a protective factor for tumor cells by inhibiting natural killer-mediated cell lysis. It also functions as a neuroblastoma cell marker, plays a role in acute and chronic transplant rejection, and modulates lymphocyte activity at mucosal surfaces. CD276/B7-H3 Protein, Cynomolgus (HEK293, His) is the recombinant cynomolgus-derived CD276/B7-H3 protein, expressed by HEK293 , with C-6*His labeled tag.

HY-P70126

	*CD276/B7-H3* Protein, Cynomolgus (HEK293, Fc)** rCynCD276/B7-H3, Fc; CD276 antigen; CD276; B7 homolog 3; B7-H3; CD276; Cynomolgus CD276 Molecule	Cynomolgus	HEK293
	CD276/B7-H3 protein can regulate T cell-mediated immune responses and act as a protective factor for tumor cells by inhibiting natural killer-mediated cell lysis. It also functions as a neuroblastoma cell marker, plays a role in acute and chronic transplant rejection, and modulates lymphocyte activity at mucosal surfaces. CD276/B7-H3 Protein, Cynomolgus (HEK293, Fc) is the recombinant cynomolgus-derived CD276/B7-H3 protein, expressed by HEK293 , with C-hFc labeled tag.

HY-P7639

	*CD276/B7-H3* Protein, Mouse (HEK293, His)** rMuB7-H3, His; CD276 antigen; CD276; B7 homolog 3; B7-H3; CD276	Mouse	HEK293
	CD276/B7-H3 Protein, Mouse (HEK293, His) is induced upon T cell activation. B7-H3 selectively increases the production of IFN-γ.

HY-P700880

	*CD276/B7-H3* Protein, Human (Biotinylated, HEK293, C-His-Avi)** B7H3; B7-H3; CD276; PSEC0249; UNQ309; PRO352; B7 homolog 3; CD276	Human	HEK293
	CD276/B7-H3 protein can regulate T cell-mediated immune responses and act as a protective factor for tumor cells by inhibiting natural killer-mediated cell lysis. It also functions as a neuroblastoma cell marker, plays a role in acute and chronic transplant rejection, and modulates lymphocyte activity at mucosal surfaces. CD276/B7-H3 Protein, Human (Biotinylated, HEK293, C-His-Avi) is the recombinant human-derived CD276/B7-H3 protein, expressed by HEK293 , with C-Avi, C-His labeled tag.

HY-P70652

	*CD276/B7-H3* Protein, Human (433a.a, HEK293, His)** CD276; B7H34Ig-B7-H3; B7-H3; B7 homolog 3; CD276 antigen; CD276 molecule; Costimulatory molecule	Human	HEK293
	CD276/B7-H3 protein can regulate T cell-mediated immune responses and act as a protective factor for tumor cells by inhibiting natural killer-mediated cell lysis. It also functions as a neuroblastoma cell marker, plays a role in acute and chronic transplant rejection, and modulates lymphocyte activity at mucosal surfaces. CD276/B7-H3 Protein, Human (433a.a, HEK293, His) is the recombinant human-derived CD276/B7-H3 protein, expressed by HEK293 , with C-His labeled tag.

HY-P74315

	*CD276/B7-H3* Protein, Rat (HEK293, Fc)** B7H3; B7-H3B7 homolog 3; CD276; Costimulatory molecule	Rat	HEK293
	CD276/B7-H3 Protein regulates T-cell-mediated immune responses and transplant rejection. It also promotes bone formation, functioning at the bone-immune interface. Additionally, it activates immune responses against tumors, eliminating them through natural killer cells and CD8 T-cells. Its interaction with TREML2 enhances T-cell activation, highlighting its role in immune regulation. CD276/B7-H3 Protein, Rat (HEK293, Fc) is the recombinant rat-derived CD276/B7-H3 protein, expressed by HEK293 , with C-hFc labeled tag.

HY-P77538

	*CD276/B7-H3* Protein, Human (Biotinylated, HEK293, His)** B7H3; B7-H3B7 homolog 3; CD276; Costimulatory molecule	Human	HEK293
	CD276/B7-H3 protein can regulate T cell-mediated immune responses and act as a protective factor for tumor cells by inhibiting natural killer-mediated cell lysis. It also functions as a neuroblastoma cell marker, plays a role in acute and chronic transplant rejection, and modulates lymphocyte activity at mucosal surfaces. CD276/B7-H3 Protein, Human (Biotinylated, HEK293, His) is the recombinant human-derived CD276/B7-H3 protein, expressed by HEK293 , with C-His labeled tag.

HY-P77578

	*CD276/B7-H3* Protein, Human (217a.a, HEK293, Fc)** B7H3; B7-H3; CD276; PSEC0249; UNQ309; PRO352; B7 homolog 3; CD276	Human	HEK293
	CD276/B7-H3 protein can regulate T cell-mediated immune responses and act as a protective factor for tumor cells by inhibiting natural killer-mediated cell lysis. It also functions as a neuroblastoma cell marker, plays a role in acute and chronic transplant rejection, and modulates lymphocyte activity at mucosal surfaces. CD276/B7-H3 Protein, Human (217a.a, HEK293, Fc) is the recombinant human-derived CD276/B7-H3 protein, expressed by HEK293 , with C-hFc labeled tag.

HY-P700448

	*CD276/B7-H3* Protein, Human (HEK293, Myc-hFc)** CD276; CD276 molecule; CD276 antigen; B7 H3; B7H3; B7RP 2; B7 homolog 3; costimulatory molecule; B7-H3; B7RP-2; 4Ig-B7-H3	Human	HEK293
	CD276/B7-H3 protein can regulate T cell-mediated immune responses and act as a protective factor for tumor cells by inhibiting natural killer-mediated cell lysis. It also functions as a neuroblastoma cell marker, plays a role in acute and chronic transplant rejection, and modulates lymphocyte activity at mucosal surfaces. CD276/B7-H3 Protein, Human (HEK293, Myc-hFc) is the recombinant human-derived CD276/B7-H3 protein, expressed by HEK293 , with C-Myc, C-hFc labeled tag.

HY-P78930

	*CD276/B7-H3* Protein, Human (Biotinylated, HEK293, Fc-Avi)** B7-H3; CD276; B7 homolog 3	Human	HEK293
	CD276/B7-H3 protein can regulate T cell-mediated immune responses and act as a protective factor for tumor cells by inhibiting natural killer-mediated cell lysis. It also functions as a neuroblastoma cell marker, plays a role in acute and chronic transplant rejection, and modulates lymphocyte activity at mucosal surfaces. CD276/B7-H3 Protein, Human (Biotinylated, HEK293, Fc-Avi) is the recombinant human-derived CD276/B7-H3 protein, expressed by HEK293 , with C-Avi, C-hFc labeled tag.

HY-P704456

	*FITC-Labeled CD276/B7-H3* Protein, Human (433a.a, HEK293, His)** CD276; CD276 molecule; CD276 antigen; B7 H3; B7H3; B7RP 2; B7 homolog 3; costimulatory molecule; B7-H3; B7RP-2; 4Ig-B7-H3;	Human	HEK293
	CD276/B7-H3 protein can regulate T cell-mediated immune responses and act as a protective factor for tumor cells by inhibiting natural killer-mediated cell lysis. It also functions as a neuroblastoma cell marker, plays a role in acute and chronic transplant rejection, and modulates lymphocyte activity at mucosal surfaces. FITC-Labeled CD276/B7-H3 Protein, Human (433a.a, HEK293, His) is the recombinant human-derived FITC-Labeled CD276/B7-H3 protein, expressed by HEK293, with C-His labeled tag.

HY-P78391

	*CD276/B7-H3* Protein, Human (HEK293, His-Avi)** B7-H3; CD276; PSEC0249; 4Ig-B7-H3; UNQ309; PRO352; B7 homolog 3; CD276	Human	HEK293
	CD276/B7-H3 protein can regulate T cell-mediated immune responses and act as a protective factor for tumor cells by inhibiting natural killer-mediated cell lysis. It also functions as a neuroblastoma cell marker, plays a role in acute and chronic transplant rejection, and modulates lymphocyte activity at mucosal surfaces. CD276/B7-H3 Protein, Human (HEK293, His-Avi) is the recombinant human-derived CD276/B7-H3 protein, expressed by HEK293 , with C-Avi, C-His labeled tag.

HY-P78074

	*CD276/B7-H3* Protein, Human (Biotinylated, HEK293, His-Avi)** B7-H3; CD276; PSEC0249; 4Ig-B7-H3; UNQ309; PRO352; B7 homolog 3; CD276	Human	HEK293
	CD276/B7-H3 protein can regulate T cell-mediated immune responses and act as a protective factor for tumor cells by inhibiting natural killer-mediated cell lysis. It also functions as a neuroblastoma cell marker, plays a role in acute and chronic transplant rejection, and modulates lymphocyte activity at mucosal surfaces. CD276/B7-H3 Protein, Human (Biotinylated, HEK293, His-Avi) is the recombinant human-derived CD276/B7-H3 protein, expressed by HEK293 , with C-Avi, C-His labeled tag.

HY-P701302

	*FITC-Labeled CD276/B7-H3* Protein, Human (435a.a, HEK293, Fc)** 4Ig-B7-H3; B7-H3; CD276; PSEC0249; UNQ309; PRO352; B7 homolog 3	Human	HEK293
	CD276/B7-H3 protein can regulate T cell-mediated immune responses and act as a protective factor for tumor cells by inhibiting natural killer-mediated cell lysis. It also functions as a neuroblastoma cell marker, plays a role in acute and chronic transplant rejection, and modulates lymphocyte activity at mucosal surfaces. FITC-Labeled CD276/B7-H3 Protein, Human (435a.a, HEK293, Fc) is the recombinant human-derived FITC-Labeled CD276/B7-H3 protein, expressed by HEK293 , with Fc labeled tag.

HY-P705245

	*CD276/B7-H3* Protein, Mouse (Biotinylated, HEK293, His-Avi)** rMuB7-H3, His; CD276 antigen; CD276; B7 homolog 3; B7-H3; CD276	Mouse	HEK293

HY-P7327

	*CD276/B7-H3* Protein, Human (HEK293, His)** rHuB7-H3/ICOSLG, His; B7H3; B7 homolog 3; CD276	Human	HEK293
	CD276/B7-H3 Protein, Human (HEK293, His) is a polypeptide chain containing the C-termimal His tag produced in HEK293 cells. B7-H3 is an immune checkpoint from the B7 family of molecules.

HY-P7326

	*CD276/B7-H3* Protein, Human (HEK293, Fc)** rHuB7-H3/ICOSLG, Fc Chimera; B7H3; B7 homolog 3; CD276	Human	HEK293
	CD276/B7-H3 Protein, Human (HEK293, Fc) is a polypeptide chain containing the C-termimal His tag produced in HEK293 cells. B7-H3 is an immune checkpoint from the B7 family of molecules.

Compare Products


Products	In-stock - + Add to Cart
Cat. No.
Species
Source
Tag
Accession
Gene ID
Molecular Weight
Purity
Endotoxin Level
Biological Activity
Appearance
Formulation
Storage & Stability
Shipping
Free Sample	Yes No
Size	* This product has been "discontinued". Optimized version of product available: / In-stock - + Add to Cart Get quote

Cat. No.	Compare	Product Name	Application	Reactivity

HY-P84637

	CD276 Antibody (YA4334) B7H3; B7-H3; 4Ig-B7-H3; CD276	WB, IHC-P, ICC/IF, FC, ELISA	Human, Mouse, Rat, Rabbit, Monkey
	CD276 Antibody (YA4334) is a mouse-derived and non-conjugated IgG1 antibody, targeting to CD276. It can be applicated for WB, IHC-P, ICC/IF, FC, ELISA assays, in the background of human, mouse, rat, rabbit, monkey.

HY-P84983

	*CD276/B7H3* Antibody (YA4675)** CD276; B7H3; PSEC0249; CD276 antigen; 4Ig-B7-H3; B7 homolog 3; B7-H3; Costimulatory molecule; CD antigen CD276; CD276 nanobody; B7H3 nanobody	ELISA	Human
	CD276/B7H3 Antibody (YA4675) is a mouse-derived and non-conjugated monoclonal antibody, targeting to CD276/B7H3. It can be applicated for ELISA assays, in the background of human.

HY-P81534

	CD276 Antibody (YA1279) CD276; B7H3; PSEC0249; CD276 antigen; 4Ig-B7-H3; B7 homolog 3; B7-H3; Costimulatory molecule; CD276	IHC-P	Human
	CD276 Antibody (YA1279) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1279), targeting CD276. CD276 Antibody (YA1279) can be used for IHC-P experiment in human background.

HY-P85833

	CD276 Antibody (YA5525) CD276; B7H3; PSEC0249; CD276 antigen; 4Ig-B7-H3; B7 homolog 3; B7-H3; Costimulatory molecule; CD276	WB, ICC/IF, ELISA	Human, Mouse, Rat
	CD276 Antibody (YA5525) is a mouse-derived and non-conjugated monoclonal antibody, targeting to CD276. It can be applicated for WB, ICC/IF, ELISA assays, in the background of human, mouse, rat.

HY-P85087

	CD276 Antibody (YA4779) CD276; B7H3; PSEC0249; CD276 antigen; 4Ig-B7-H3; B7 homolog 3; B7-H3; Costimulatory molecule; CD antigen CD276	WB, IHC-P, ICC/IF, FC, ELISA	Human
	CD276 Antibody (YA4779) is a mouse-derived and non-conjugated monoclonal antibody, targeting to CD276. It can be applicated for WB, IHC-P, ICC/IF, FC, ELISA assays, in the background of human.

Compare Products


Products	In-stock - + Add to Cart
Cat. No.
Host
Reactivity
Application
Dilution Ratio
Molecular Weight
Conjugation
Clonality
Immunogen
Appearance
Isotype
Gene ID
SwissProt ID
Purity
Formulation
Free Sample	Yes No
Size	* This product has been "discontinued". Optimized version of product available: / In-stock - + Add to Cart Get quote

Inquiry Online

Your information is safe with us. * Required Fields.

MCE Japan Authorized Agent ナミキ商事株式会社コスモ・バイオ株式会社重松貿易株式会社
Salutation			Country or Region *
Applicant Name *			Organization Name *
Department *
Email Address *			Product Name *
Cat. No.			Requested quantity *
Phone Number *
Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: